Idarucizumab reverses dabigatran-induced anticoagulation in treatment of gastric bleeding: A case report

BACKGROUND: The drug instructions for dabigatran recommend adjusting the dosage to 110 mg twice daily for patients with bleeding risk, and performing at least one renal function test per year for patients with moderate renal impairment. However, owing to chronic insidiously worsening renal insuffici...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Yu, Wang, Shao-Hua, Cui, Na-Juan, Liu, Quan-Xi, Wang, Wei, Li, Xue, Gu, Ya-Mei, Zhu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968591/
https://www.ncbi.nlm.nih.gov/pubmed/35434066
http://dx.doi.org/10.12998/wjcc.v10.i8.2537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968591/
https://www.ncbi.nlm.nih.gov/pubmed/35434066
http://dx.doi.org/10.12998/wjcc.v10.i8.2537

Ejemplares similares